← Eichor
Study identifier: NCT07648680 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

"Menopause Experiences in Cultural and Intercultural Contexts"

Condition: Valid MeSH Conditions  ·  Sponsor: Institut Investigacio Sanitaria Pere Virgili

PhaseN/A
Planned participants25
Who can joinFemale, 40 Years to 65 Years
Healthy volunteersNo

About this study

The climacteric period involves physical, hormonal, and emotional changes that can impact a woman's quality of life. This mixed-methods study aims to explore the perceptions and experiences of women during menopause and the influence of cultural ethnicity on their quality of life in Primary Care centers in Tarragona. The research includes a quantitative phase to assess healthcare professionals' knowledge via electronic surveys and a qualitative phase using individual interviews with women from diverse backgrounds. The goal is to identify specific needs to adapt community nursing interventions and improve health promotion and equity during the climacteric stage.

This description comes directly from the study's public registry record.

Talk to the study team

Rocío Legaz Pagán, PhD Student, RN, BcS  ·  +34646057662  ·  rlegazpagan39@gmail.com

Marina Gómez de Quero Cordoba, RN, MSN, PhD  ·  marina.gomezdequero@urv.cat

Always discuss trial participation with your own doctor first.

Locations (1)

Institut Català de la Salut (ICS) - Camp de Tarragona.Tarragona, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07648680